CVS Health (CVS) Tops Q4 EPS by 5c, Revenue Beats, Offers FY20 Guidance

CVS Health (NYSE: CVS) reported Q4 EPS of $1.73, $0.05 better than the analyst estimate of $1.68. Revenue for the quarter came in at $66.9 billion versus the consensus estimate of $63.97 billion.

GUIDANCE:

CVS Health sees FY2020 EPS of $7.04-$7.17, versus the consensus of $7.15.

• GAAP operating income in the range of $12.8 billion to $13.0 billion
• Adjusted operating income (1) in the range of $15.5 billion to $15.8 billion
• GAAP diluted EPS from continuing operations in the range of $5.47 to $5.60
• Adjusted EPS (2) in the range of $7.04 to $7.17
• Cash flow from operations in the range of $10.5 billion to $11.0 billion

For earnings history and earnings-related data on CVS Health (CVS) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• What Delta’s report tells investors in American and United
• CVS Health (CVS) Declares $.665 Quarterly Dividend; 2.6% Yield